Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 142


Late expression of granulysin by microbicidal CD4+ T cells requires PI3K- and STAT5-dependent expression of IL-2Rbeta that is defective in HIV-infected patients.

Zheng CF, Jones GJ, Shi M, Wiseman JC, Marr KJ, Berenger BM, Huston SM, Gill MJ, Krensky AM, Kubes P, Mody CH.

J Immunol. 2008 Jun 1;180(11):7221-9.


Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARgamma/STAT5 signaling pathway in macaques.

Prost S, Le Dantec M, Augé S, Le Grand R, Derdouch S, Auregan G, Déglon N, Relouzat F, Aubertin AM, Maillere B, Dusanter-Fourt I, Kirszenbaum M.

J Clin Invest. 2008 May;118(5):1765-75. doi: 10.1172/JCI33037.


Cytokine signaling modules in inflammatory responses.

O'Shea JJ, Murray PJ.

Immunity. 2008 Apr;28(4):477-87. doi: 10.1016/j.immuni.2008.03.002. Review.


IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.

Sommereyns C, Paul S, Staeheli P, Michiels T.

PLoS Pathog. 2008 Mar 14;4(3):e1000017. doi: 10.1371/journal.ppat.1000017.


Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.

Hennighausen L, Robinson GW.

Genes Dev. 2008 Mar 15;22(6):711-21. doi: 10.1101/gad.1643908. Review.


The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8.

Esashi E, Wang YH, Perng O, Qin XF, Liu YJ, Watowich SS.

Immunity. 2008 Apr;28(4):509-20. doi: 10.1016/j.immuni.2008.02.013. Epub 2008 Mar 13.


Stimulation of inducible nitric oxide synthase expression by beta interferon increases necrotic death of macrophages upon Listeria monocytogenes infection.

Zwaferink H, Stockinger S, Reipert S, Decker T.

Infect Immun. 2008 Apr;76(4):1649-56. doi: 10.1128/IAI.01251-07. Epub 2008 Feb 11.


IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia.

Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK.

Nat Med. 2008 Mar;14(3):275-81. doi: 10.1038/nm1710. Epub 2008 Feb 10.


An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity.

Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR.

J Immunol. 2008 Feb 15;180(4):2474-85.


Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5.

Xiao W, Hong H, Kawakami Y, Lowell CA, Kawakami T.

J Clin Invest. 2008 Mar;118(3):924-34. doi: 10.1172/JCI34013.


Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.

Grebien F, Kerenyi MA, Kovacic B, Kolbe T, Becker V, Dolznig H, Pfeffer K, Klingmüller U, Müller M, Beug H, Müllner EW, Moriggl R.

Blood. 2008 May 1;111(9):4511-22. doi: 10.1182/blood-2007-07-102848. Epub 2008 Jan 31.


Accumulation of effector CD4 T cells during type 2 immune responses is negatively regulated by Stat6.

King SB, Knorn AM, Ohnmacht C, Voehringer D.

J Immunol. 2008 Jan 15;180(2):754-63.


Type I interferon as a stimulus for cross-priming.

Le Bon A, Tough DF.

Cytokine Growth Factor Rev. 2008 Feb;19(1):33-40. Review.


The Mx GTPase family of interferon-induced antiviral proteins.

Haller O, Stertz S, Kochs G.

Microbes Infect. 2007 Nov-Dec;9(14-15):1636-43. Epub 2007 Sep 14. Review.


Structure and function of the protein kinase R.

Sadler AJ, Williams BR.

Curr Top Microbiol Immunol. 2007;316:253-92. Review.


Interleukin-21: basic biology and implications for cancer and autoimmunity.

Spolski R, Leonard WJ.

Annu Rev Immunol. 2008;26:57-79. Review.


High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells.

Miyagi T, Gil MP, Wang X, Louten J, Chu WM, Biron CA.

J Exp Med. 2007 Oct 1;204(10):2383-96. Epub 2007 Sep 10.


IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes.

Osterlund PI, Pietilä TE, Veckman V, Kotenko SV, Julkunen I.

J Immunol. 2007 Sep 15;179(6):3434-42.

Supplemental Content

Support Center